H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Census population 156,607. Kansas Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Kansas City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Kansas City storefront.
Orthobiologic Treatments for Your Practice in Kansas City, KS for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Obesity 41.2%; arthritis 23.3%. Those three PLACES crude rates (plus Census 156,607) are the local facts on this page. Everything else is the national orthobiologic treatments catalog and J5 paperwork.
National Orthobiologic Treatments for Your Practice notes (how the product actually works)Kansas shares J5 with IA, MO, NE. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Adult arthritis here is 23.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Kansas City.
CDC PLACES (2023, crude prevalence) estimates 14.6% of adults — 2.6 points above the U.S. 12% figure. Obesity is 41.2%; arthritis is 23.3%. That is place-level BRFSS modeling, not a clinic census and not a Kansas City trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Kansas.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed Kansas clinician.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what J5 reviewers and surveyors expect — not a brochure.
Bring specialty, monthly joint / regenerative volume, and whether you bill J5 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 14.6% diabetes and 23.3% arthritis for Kansas City — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Kansas City, KS.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Kansas City is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Kansas City — 2.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Kansas Part B wound biologics follow this contractor (siblings: IA, MO, NE). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Kansas City. Useful for joint-program math; still needs a diagnosis and privileging.
No Kansas City storefront. Joe Bradley is an active practice owner. orthobiologic treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.